Moscow: India and China may start producing Russia’s Sputnik V vaccine against COVID-19, the RIA news agency cited President Vladimir Putin as saying.
Putin also proposed that the creation of a vaccine research centre for BRICS countries – Brazil, Russia, India, China and South Africa – be sped up, TASS reported.
Russia’s Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country’s sovereign wealth fund said on Nov. 11.
Russia licensed its Sputnik-V COVID-19 vaccine for domestic use in August before it started large-scale trials.
In September, Dr Reddy’s and the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.
As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr Reddy’s upon regulatory approval in India. (Mint)Read More